A. Senthilmurugan, I. S. Aidhen / Carbohydrate Research 347 (2012) 55–63
61
4.6. 2-((2-((4S,40R,5R)-2,2,20,20-Tetramethyl-[4,40-bi(1,3-di-
oxolan)]-5-yl)ethyl)thio)benzo[d] thiazole (18)
(m, 1H), 3.81 (d, 1H, J = 2.80 Hz), 4.21–4.28 (m, 1H), 4.45 (d, 1H,
J = 12.0 Hz, OCHaHbPh), 4.59 (d, 1H, J = 4.0 Hz, 6a-CH), 4.67 (d, 1H,
J = 12.0 Hz, –OCHaHbPh), 5.86 (d, 1H, J = 4.0 Hz, 3a-CH), 7.23–7.34
(m, 5H, –OCH2C5H5), 7.57–7.67 (m, 2H, ArH), 8.01 (d, 1H,
J = 7.60 Hz, ArH), 8.19 (d, 1H, J = 7.6 Hz, ArH). 13C NMR [CDCl3,
100 MHz] d 21.8, 26.2, 26.7, 51.9, 71.7, 77.8, 81.7, 82.1, 104.7,
111.7, 122.5, 125.5, 127.7, 127.9, 128.0, 128.1, 128.6, 136.8,
136.9, 152.7, 165.5. HRMS (ESI): m/z Calcd for C23H26NO6S2
[M+H]+: 476.1202. Found: 476.1226.
By following general procedure C, bromide 16 was converted to
sulfide 18. Yield: 73%. Rf: 0.4 (hexanes/ethyl acetate, 9.2:0.8), col-
ourless gum. ½a D
ꢂ
+9.283 (c = 1, CH2Cl2); IR (CH2Cl2): 1076, 1146,
1266, 1328, 1377, 1470, 2981 cmꢁ1
.
1H NMR [CDCl3, 400 MHz] d
1.21 (s, 3H, –CH3), 1.25 (s, 3H, –CH3), 1.29 (s, 3H, –CH3), 1.34 (s,
3H, –CH3), 1.96–2.07 (m, 1H, –CH2CH2S), 2.20–2.30 (m, 1H, –
CH2CH2S), 3.30–3.40 (m, 1H), 3.46–3.54 (m, 1H), 3.53 (t, 1H,
J = 8.0 Hz, 5h-CHaHb), 3.84–3.89 (m, 2H), 3.92–3.99 (m, 3H),
4.00–4.08 (m, 2H), 7.21 (t, 1H, J = 8.0 Hz, ArH), 7.33 (t, 1H,
J = 8.0 Hz, ArH), 7.67 (d, 1H, J = 8.0 Hz, ArH), 7.78 (d, 1H,
J = 8.0 Hz, ArH). 13C NMR [CDCl3, 100 MHz] d 25.2, 26.7, 27.0,
27.3, 30.1, 33.5, 67.8, 79.0, 81.1, 109.4, 121.0, 121.5, 124.2, 126.0,
135.2, 153.3, 166.8. HRMS (ESI): m/z Calcd for C19H26NO4S2
[M+H]+: 396.1303. Found: 396.1316.
4.10. (4S,40R,5R)-5-(3-(4-(2-((S)-2,2-Dimethyl-1,3-dioxolan-4-
yl)ethyl)phenyl)propyl)-2,2,20,20-tetramethyl-4,40-bi(1,3-diox-
olane) (22a)
By following the general procedure A and general procedure E,
compound 12 was converted to 22a. Yield: 65%. Rf: 0.55 (hexanes/
ethyl acetate, 9:1), colourless liquid. ½a D
ꢂ
+1.597 (c = 1, CH2Cl2); IR
(CH2Cl2): 1024, 1086, 1230, 1382, 1440, 2898, 2932 cmꢁ1
.
1H
4.7. 2-((2-((3aR,5R,6S,6aR)-6-(Benzyloxy)-2,2-dimethyltetra-
hydrofuro[2,3-d][1,3]dioxol-5-yl) ethyl)thio)benzo[d]thiazole
(20a)
NMR [CDCl3, 400 MHz] d 1.33 (s, 3H, –CH3), 1.34 (s, 3H, –CH3),
1.35 (s, 3H, –CH3), 1.36 (s, 3H, –CH3), 1.37 (s, 3H, –CH3), 1.42 (s,
3H, –CH3), 1.66–2.00 (m, 6H), 2.56–2.80 (m, 4H), 3.49–3.58 (m,
2H), 3.89–3.97 (m, 2H), 3.98–4.04 (m, 2H), 4.06–4.15 (m, 2H),
7.06–7.12 (m, 4H, ArH). 13C NMR [CDCl3, 100 MHz] d 25.3, 25.7,
26.7, 27.0, 27.4, 27.7, 31.6, 33.2, 35.4, 67.7, 69.3, 75.5, 77.2, 80.3,
81.0, 108.7, 109.5, 128.2, 128.5, 138.8, 139.9. HRMS (ESI): m/z
Calcd for C26H40O6 [M+H]+: 449.2903. Found: 449.2912.
By following general procedure C, bromide 20 was converted to
sulfide 20a. Yield: 78%. Rf: 0.4 (hexanes/ethyl acetate, 9.2:0.8), col-
ourless gum. ½a D
ꢂ
ꢁ15.023 (c = 1, CH2Cl2); IR (CH2Cl2): 1051, 1071,
1216, 1254, 1376, 2927, 2987 cmꢁ1
.
1H NMR [CDCl3, 400 MHz] d
1.24 (s, 3H, –CH3), 1.40 (s, 3H, –CH3), 2.00–2.30 (m, 2H, –SCH2CH2),
3.18–3.28 (m, 1H, –SCH2CHaHb), 3.36–3.45 (m, 1H, –SCH2CHaHb),
3.78 (d, 1H, J = 2.8 Hz, 6-CH), 4.24–4.31 (m, 1H, 5-CH), 4.42 (d,
1H, J = 11.6 Hz, –OCHaHbPh), 4.55 (d, 1H, J = 3.6 Hz, 6a-CH), 4.62
(d, 1H, J = 12.0 Hz, –OCHaHbPh), 5.85 (d, 1H, J = 3.6 Hz, 3a-CH),
7.15–7.25 (m, 5H, –OCH2Ph; 1H, BT-H), 7.31–7.35 (m, 1H, ArH),
7.66 (d, 1H, J = 8.0 Hz, ArH), 7.77 (d, 1H, J = 8.0 Hz, ArH), 8.19 (d,
1H, J = 7.6 Hz, ArH). 13C NMR [CDCl3, 100 MHz] d 26.2, 26.7, 28.1,
30.3, 71.8, 78.8, 82.0, 82.3, 104.7, 111.5, 120.9, 121.5, 124.1,
126.0, 127.7, 128.0, 135.2, 137.3, 153.3, 166.8. HRMS (ESI): m/z
Calcd for C23H26NO4S2 [M+H]+: 444.1303. Found: 444.1298.
4.11. (3aR,5R,6S,6aR)-6-(Benzyloxy)-5-(3-(4-(2-((S)-2,2-di-
methyl-1, 3-dioxolan-4-yl)ethyl)phenyl)propyl)-2,2-dimethyl
tetrahydrofuro[2,3-d][1,3]dioxole (22b)
By following the general procedure A and general procedure E,
compound 12 was converted to 22b. Yield: 62%. Rf: 0.4 (hexanes/
ethyl acetate, 9:1), colourless liquid. ½a D
ꢂ
ꢁ5.043 (c = 2, CH2Cl2);
IR (CH2Cl2): 1074, 1162, 1215, 1374, 2865, 2930, 2987 cmꢁ1
.
1H
NMR [CDCl3, 400 MHz] d 1.31 (s, 3H, –CH3), 1.36 (s, 3H, –CH3),
1.43 (s, 3H, –CH3), 1.47 (s, 3H, –CH3), 1.66–2.00 (m, 6H), 2.54–
2.78 (m, 4H), 3.52 (t, 1H, J = 7.6 Hz), 3.75 (d, 1H, J = 2.8 Hz), 3.98–
3.44 (m, 1H), 4.06–4.16 (m, 2H), 4.45 (d, 1H, J = 12.0 Hz,
OCHaHbPh), 4.60 (d, 1H, J = 4.0 Hz, 6a-CH), 4.68 (d, 1H, J = 12.0 Hz,
–OCHaHbPh), 5.90 (d, 1H, J = 4.0 Hz, 3a-CH), 7.06 (d, 2H, J = 8.4 Hz,
ArH), 7.29–7.37 (m, 5H, ArH). 13C NMR [CDCl3, 100 MHz] d 25.8,
26.3, 26.8, 27.1, 27.7, 28.0, 31.7, 35.5, 35.6, 69.4, 71.8, 75.5, 80.4,
81.9, 81.9, 82.2, 104.7, 108.8, 111.3, 127.8, 128.0, 128.3, 128.6,
137.7, 138.9, 139.9. HRMS (ESI): m/z Calcd for C30H40O6 Na
[M+Na]+: 519.2723. Found: 519.2727.
4.8. 2-((2-((4S,40R,5R)-2,2,20,20-Tetramethyl-[4,40-bi(1,3-di-
oxolan)]-5-yl)ethyl)sulfonyl)benzo[d]thiazole (14)
By following general procedure D, sulfide 18 was oxidized to sul-
fone 14. Yield: 73%. Rf: 0.4 (hexanes/ethyl acetate, 7:3), colourless
crystals, mp: 90 °C. ½a D
ꢂ
+10.978 (c = 1, CH2Cl2); IR (CH2Cl2): 1076,
1146, 1266, 1328, 1377, 1470, 2981 cmꢁ1
.
1H NMR [CDCl3,
400 MHz] d 1.25 (s, 3H, –CH3), 1.28 (s, 3H, –CH3), 1.29 (s, 3H, –
CH3), 1.32 (s, 3H, –CH3), 2.08–2.20 (m, 1H, –CHCH2CH2), 2.31–2.43
(m, 1H, –CHCH2CH2), 3.50 (t, 1H, J = 7.6 Hz, 5h-CHaHb), 3.60–3.83
(m, 2H), 3.87–4.01 (m, 3H), 4.08–4.11 (dd, 1H, J = 8.0 Hz, 5.6 Hz),
7.59 (t, 1H, J = 7.2 Hz, ArH), 7.64 (d, 1H, J = 7.6 Hz, ArH), 8.01 (d,
1H, J = 7.6 Hz, ArH), 8.21 (d, 1H, J = 8.0 Hz, ArH).13C NMR [CDCl3,
100 MHz] d 25.2, 26.6, 26.7, 27.0, 27.2, 51.9, 67.9, 77.0, 78.3, 81.2,
109.7, 109.8, 122.4, 125.5, 128.1, 136.8, 152.8, 165.6. HRMS (ESI):
m/z Calcd for C19H26NO6S2 [M+H]+: 428.1202. Found: 428.1203.
4.12. (4S,40R,5R)-2,2,20,20-Tetramethyl-5-(3-(4-(2-((4R,40R,5S)-
2,2,20,20-tetramethyl-[4,40-bi(1,3-dioxolan)]-5-yl)ethyl)phen-
yl)propyl)-4,40-bi(1,3-dioxolane) (22c)
By following the general procedure A and general procedure E,
compound 13 was converted to 22c. Yield: 67%. Rf: 0.5 (hexanes/
ethyl acetate, 9:1), colourless gum. ½a D
ꢂ
+11.597 (c = 3, CH2Cl2); IR
(CH2Cl2): 1066, 1086, 1215, 1253, 1374, 2928, 2980 cmꢁ1
.
1H
4.9. 2-((2-((3aR,5R,6S,6aR)-6-(Benzyloxy)-2,2-dimethyltetra-
hydrofuro[2,3-d][1,3]dioxol-5-yl) ethyl)sulfonyl)benzo[d]thi-
azole (21)
NMR [CDCl3, 400 MHz] d 1.33 (s, 3H, –CH3), 1.34 (s, 6H, 2 ꢀ –
CH3), 1.36 (s, 3H, –CH3), 1.37 (s, 6H, 2 ꢀ –CH3), 1.39 (s, 3H, –CH3),
1.42 (s, 3H, –CH3), 1.50–1.90 (m, 10H), 2.00–2.10 (m, 2H), 2.60–
2.74 (m, 3H), 2.77–2.87 (m, 1H), 3.50–3.65 (m, 2H), 3.89–3.98
(m, 4H), 3.98–4.50 (m, 2H), 4.08–4.15 (m, 2H), 7.08–7.15 (m, 4H,
ArH). 13C NMR [CDCl3, 100 MHz] d 25.4, 26.8, 26.9, 27.1, 27.2,
27.5, 27.54, 27.8, 31.8, 32.0, 33.3, 35.5, 35.6, 67.8 (2 ꢀ –CH2O),
77.2, 77.4, 80.0, 80.4, 81.1, 81.2, 108.9, 109.0, 109.6, 109.7, 128.4,
128.5, 139.3, 139.8. HRMS (ESI): m/z Calcd for C31H49O8 [M+H]+:
549.3348. Found: 549.3356.
By following general procedure D, sulfide 20a was oxidised to
sulfone 21. Yield: 75%. Rf: 0.3 (hexanes/ethyl acetate, 4:1), colour-
less gum. ½a D
ꢂ
ꢁ16.855 (c = 0.9, CH2Cl2); IR (CH2Cl2): 1071, 1216,
1254, 1376, 2927, 2987 cmꢁ1
.
1H NMR [CDCl3, 400 MHz] d 1.29
(s, 3H, –CH3), 1.42 (s, 3H, –CH3), 2.14–2.25 (m, 1H, –CHCHaHbCH2),
2.30–2.42 (m, 1H, –CHCHaHbCH2), 3.47–3.57 (m, 1H), 3.64–3.74